H. M. & Company Medisales Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.36 Cr
as on 24-10-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.50 M
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit -120.59%
(FY 2023)
- Ebitda 95.13%
(FY 2023)
- Net Worth -0.31%
(FY 2023)
- Total Assets -4.08%
(FY 2023)
About H. M. & Company Medisales
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.36 Cr.
The company currently has active open charges totaling ₹14.00 Cr. The company has closed loans amounting to ₹3.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mahendra Jain, Roshan Jain, Akshat Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397PN2011PTC139924
- Company No.
139924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at H. M. & Company Medisales?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Jain  | Director | 01-Jan-2014 | Current |
| Roshan Jain | Director | 01-Jan-2014 | Current |
| Akshat Jain | Director | 18-Jul-2011 | Current |
| Akash Jain | Director | 31-Jan-2014 | Current |
Financial Performance of H. M. & Company Medisales.
H. M. & Company Medisales Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 120.59% decrease in profit. The company's net worth dipped by a decrease of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of H. M. & Company Medisales?
In 2023, H. M. & Company Medisales had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zyphar's Pharmaceutics Private LimitedActive 18 years 10 monthsMahendra Jain and Roshan Jain are mutual person
Sinsan Pharmaceuticals Private LimitedActive 17 years 1 monthMahendra Jain and Roshan Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 May 2017 | ₹7.00 Cr | Open |
Bank Of Maharashtra Creation Date: 27 Nov 2012 | ₹7.00 Cr | Open |
Bank Of Maharashtra Creation Date: 14 Mar 2014 | ₹3.50 M | Satisfied |
How Many Employees Work at H. M. & Company Medisales?
H. M. & Company Medisales has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H. M. & Company Medisales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H. M. & Company Medisales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
